OPPORTUNITIES OF MINIMALLY INVASIVE AND TRADITIONAL INTERVENTIONS IN THE TREATMENT OF ACUTE PANCREATITIS
Abstract
Currently, pancreatitis occupies one of the leading positions among causes of the “acute abdomen.” However, debates regarding optimal treatment tactics still continue due to the lack of a unified classification and diagnostic–therapeutic algorithm. Acute pancreatitis is considered a disease of a mixed (intensive care–surgical) profile. Despite the use of modern detoxification technologies, the development of new surgical methods, and improvements in pharmacological therapy, mortality rates remain high, reaching up to 20% in sterile pancreatic necrosis and 60–80% in infected forms of acute pancreatitis [1,5,6,7,9].
References
Bagnenko S.F., Rukhlyada N.V., Tolstoy A.D. et al. Treatment of Acute Pancreatitis at the Early Stage of the Disease. St. Petersburg: I.I. Dzhanelidze Research Institute of Emergency Medicine, 2002, 24 p.Beloborodova N.V., Bachinskaya E.N. Immunological aspects of postoperative sepsis. Anesthesiology and Reanimatology. 2000;1:59–66.
Beskosny A.A., Kasumyan S.A. Prognostic criteria for severe acute pancreatitis. Annals of Surgical Hepatology. 2003;1:24–32.
Briskin B.S. Immune disorders and immunocorrection in intra-abdominal infection. Surgery (Supplement). 2004;1:16–21.
Dale M.M., Foreman J.C. Handbook of Immunopharmacology. Moscow: Medicina, 1998, 332 p.
Ermolov A.S. Immunological assessment of severity and prognosis of acute pancreatitis. Herald of Surgery. 2005;6:22–28.
Eryukhina I.A. et al. Surgical Infections: A Guide. Moscow–St. Petersburg: Piter, 2003, 864 p.
